Optimizing Success for Community Physicians
Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL).
Limited-Duration Therapy Based on MRD Testing
Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of limited duration therapy.
Developing Clinical Trials for Newly Diagnosed Disease
Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL).
Oral Oncolytics Versus Intravenous: Safety and Efficacy
A comparison of the safety and efficacy of orally and intravenously administered oncolytics.